Back to results
US 2005/0239737 A1Published application
Identification of molecular interaction sites in RNA for novel drug discovery
AssigneeIsis Pharmaceuticals, Inc.
InventorsDavid Ecker, Ranga Sampath, Richard Griffey, John McNeil
Life of this patent
Estimating the term…
Abstract
Methods of identifying molecular interaction sites in eukaryotic and prokaryotic nucleic acids, especially RNA, are described. Secondary structural elements are identified from highly conserved sequences. Methods of preparing databases relating to such molecular interaction sites are also provided herein as are databases themselves. Therapeutic, agricultural, industrial, and other applicability results from interaction of such molecular interaction sites with “small” and other molecules.
Claims18
An isolated oligonucleotide comprising a molecular interaction site, wherein:
- the molecular interaction site consists of less than 50 nucleotides;
- the molecular interaction site is present in the RNA of a selected organism and in the RNA of at least one additional organism;
- the molecular interaction site serves as a binding site for at least one molecule that when bound to the molecular interaction site modulates the expression of the RNA in the selected organism;
- and
- the oligonucleotide does not comprise an iron response element or 3′ untranslated region of a histone mRNA.
2 more elements
Dependencies are inferred from the claim text.